US Doctor flown back to the US is improving after being treated with a special and new drug called zmapp
He was close to death and could not breathe on his own
but now he can move on his own.

And he is feeling better, this is the first serum
that have been used to treat ebola.

Great
No source?.....

nice.

Finally, the ebola cure is here.

Not a really a cure yet there maybe side effects that are unknown but
i think researchers will rush to find a lasting solution to this epidemic!

Us should deply this drug to nigeria abeg oo

San Diego-based Mapp Biopharmaceutical on Monday identified the drug used to treat two Americans with Ebola as “ZMapp” and said it is working with commercial and government partners to quickly increase production.

“We are in the midst of an intense effort to help address the Ebola outbreak in West Africa,” said Mapp’s president, Larry Zeitlin, in an email message to Times of San Diego.

CNN reported that doses of the drug were flown to Africa last week and apparently saved the lives of two American stricken with the deadly virus.

Mapp said in a statement that ZMapp is composed of three “humanized” monoclonal antibodies manufactured in plants, specifically Nicotiana. It is an optimized cocktail combining the best components from Mapp’s MB-003 and ZMab developed in Canada.

The drug is a collaboration of between Mapp, LeafBio in San Diego, Defyrus in Toronto, the U.S. government and the Public Health Agency of Canada.

“ZMapp was first identified as a drug candidate in January 2014 and has not yet been evaluated for safety in humans. As such, very little of the drug is currently available,” the company noted. “Mapp and its partners are cooperating with appropriate government agencies to increase production as quickly as possible.”

Experimental Ebola Serum Grown in Tobacco Leaves
By Brenda Goodman, MA
WebMD Health News Reviewed by Michael W. Smith, MD
Aug. 4, 2014 -- ZMapp, the experimental treatment rushed to two Americans infected with Ebola in Africa, is grown in specially modified leaves of tobacco -- a plant better known for harming health than healing.

“We complied with a request from Emory University and Samaritan’s Purse to provide a very limited amount of ZMapp last week,” says David Howard, a spokesman for Reynolds American Services, the parent company of Kentucky BioProcessing. The small biopharma company in Owensboro, KY, has been contracted to grow the drug.

Making the serum is slow, in part, because the plants must be grown for several weeks before they are “infected” with a type of protein. “Basically the plants act like a photocopier of the proteins,” Howard says.